Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.325 USD | +3.26% | +3.14% | -14.58% |
04-04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
04-04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
- Stock Market
- Equities
- ABOS Stock
- News Acumen Pharmaceuticals, Inc.